I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
4.090
+0.190 (4.87%)
At close: Sep 12, 2025, 4:00 PM EDT
4.080
-0.010 (-0.24%)
After-hours: Sep 12, 2025, 6:40 PM EDT
I-Mab Market Cap
I-Mab has a market cap or net worth of $470.84 million as of September 12, 2025. Its market cap has increased by 363.04% in one year.
Market Cap
470.84M
Enterprise Value
308.71M
1-Year Change
363.04%
Ranking
Category
Stock Price
$4.09
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has increased from $138.05M to $470.84M, an increase of 241.07%. That is a compound annual growth rate of 24.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 470.32M | 579.47% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.45B |
| Johnson & Johnson | 423.36B |
| AbbVie | 373.87B |
| UnitedHealth Group | 314.07B |
| AstraZeneca | 250.26B |
| Novo Nordisk | 244.96B |
| Novartis AG | 244.56B |
| Abbott Laboratories | 225.15B |